DUBLIN, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...

The biotech sector staged a robust comeback in 2025, with the Nasdaq Biotechnology Index climbing 33.8%. Although concerns about potential high tariffs initially hurt the industry, sentiment among ...

In the world of biotechnology investing, companies often struggle to bring new drugs to market. Developing treatments for rare diseases can be incredibly expensive, and because these conditions affect ...

DUBLIN, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

- TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA 1 positive operations in Q3 2025 and expects to achieve strong ...

Biotech stories typically tread a very fine line between promise and pressure. Sometimes a company that’s been a pioneer in rare diseases suddenly finds itself at a crossroads. 💵💰Don’t miss the move ...

The MarketWatch News Department was not involved in the creation of this content. - TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of ...

The "Top 1000 Major Pharmaceutical Companies 2025" directory has been added to ResearchAndMarkets.com's offering. Essential for those doing business in the global pharmaceutical and biotechnology ...

WASHINGTON, DC (ANI) – U.S. lawmakers and industry leaders are intensifying calls for stricter export controls to prevent American biopharmaceutical companies from collaborating with China military on ...